BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
-82.68%
↓ 1303% vs avg
Percentile
P28
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
6.88%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -82.68% |
| Q3 2025 | 102.32% |
| Q2 2025 | 6.69% |
| Q1 2025 | -4.66% |
| Q4 2024 | -17.46% |
| Q3 2024 | 106.66% |
| Q2 2024 | 653.27% |
| Q1 2024 | 239.66% |
| Q4 2023 | -108.21% |
| Q3 2023 | 137.11% |
| Q2 2023 | 147.96% |
| Q1 2023 | -233.74% |
| Q4 2022 | -124.27% |
| Q3 2022 | 332.23% |
| Q2 2022 | 137.04% |
| Q1 2022 | -129.38% |
| Q4 2021 | -143.26% |
| Q3 2021 | 27.44% |
| Q2 2021 | -29.41% |
| Q1 2021 | 291.98% |
| Q4 2020 | -163.77% |
| Q3 2020 | 1311.48% |
| Q2 2020 | 89.69% |
| Q1 2020 | -950.08% |
| Q4 2019 | -81.11% |
| Q3 2019 | 155.34% |
| Q2 2019 | 24.97% |
| Q1 2019 | -1246.32% |
| Q4 2018 | 374.35% |
| Q3 2018 | 95.28% |
| Q2 2018 | 22.43% |
| Q1 2018 | -187.52% |
| Q4 2017 | -503.25% |
| Q3 2017 | 85.54% |
| Q2 2017 | 80.62% |
| Q1 2017 | -191.94% |
| Q4 2016 | -39.52% |
| Q3 2016 | 48.67% |
| Q2 2016 | 67.00% |
| Q1 2016 | -26.13% |